Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | P6 - Poster Session 6

Sunday 04/03/22
05:30 PM - 06:30 PM PDT Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Neuro-oncology, Aging, Dementia, Cognitive, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuromuscular and Clinical Neurophysiology (EMG)
0.00 CME credit

Program Materials Program Evaluations

Event Timeline
05:30 PM - 06:30 PM PDT Abstract 9-001 - Characterization of Neurosarcoid Myelitis and Assessment of Treatment Response in a Single-Hospital System.
Giovanna Manzano, MD
05:30 PM - 06:30 PM PDT Abstract 9-002 - Identification of Brain and Spinal Cord Abscesses in a Patient with Recently Diagnosed Neurosarcoidosis
Karishma Anjuli Popli, MD, MBE
05:30 PM - 06:30 PM PDT Abstract 9-003 - Stroke in Patients with Sarcoidosis: A Comprehensive Review of 42 Reported Cases
Danielle Kei Pua, MD
05:30 PM - 06:30 PM PDT Abstract 9-004 - “String of pearls” in the spinal cord: a novel magnetic resonance imaging sign in necrotizing sarcoid granulomatosis myelitis
Xiaoyang Li, MD
05:30 PM - 06:30 PM PDT Abstract 9-005 - Neurosarcoidosis after infection with COVID-19, a case report and review of the literature
Daniel Esteban Mafla Delgado, Sr., MD
05:30 PM - 06:30 PM PDT Abstract 9-006 - Primary angitis of the central nervous system (PANCS) mimicking Glioblastoma in a pediatric patient
Alfred Balasa, MD
05:30 PM - 06:30 PM PDT Abstract 9-007 - Susac Syndrome with a Unique Involvement of the Thoracic Spinal Cord
Robert Evan Ungerer
05:30 PM - 06:30 PM PDT Abstract 15-001 - Migraine and the Risk of Venous Thromboembolism among Women
Pamela M. Rist, PhD
05:30 PM - 06:30 PM PDT Abstract 15-002 - Factors Associated With Seeking Care For Migraine: Results Of The OVERCOME (US) Study
Sait Ashina, MD
05:30 PM - 06:30 PM PDT Abstract 15-003 - Validation of Measures of Treatment Expectancy in Children & Adolescents with Headache
Christina Lynch Szperka, MD
05:30 PM - 06:30 PM PDT Abstract 15-004 - Translation and validation to Spanish of the diagnostic test ID-Migraine ®
Roberto Rodriguez, MD
05:30 PM - 06:30 PM PDT Abstract 15-005 - Pediatric Pain Neuroscience Education: Pilot Trial in Primary Headache Patients
Isidora Rose Beach
05:30 PM - 06:30 PM PDT Abstract 15-006 - The Migraine Disability Assessment (MIDAS) as an Indicator of Resilience in Patients with Headaches
Deborah I. Friedman, MD, MPH, FAAN
05:30 PM - 06:30 PM PDT Abstract 3-001 - Allopregnanolone as a Regenerative Therapeutic for Early Alzheimer’s Disease: Phase 1b/2a Clinical Trial Outcomes
Gerson David Hernandez Rivera, MD, MPH
05:30 PM - 06:30 PM PDT Abstract 3-002 - PostGraduate Open-label Rollover Study: Evaluation of Subcutaneous Gantenerumab Long-term Safety, Tolerability, and Efficacy in Participants with Alzheimer’s Disease
Christopher Lane
05:30 PM - 06:30 PM PDT Abstract 3-003 - Development of the Monoclonal Antibody AL101 to block the Sortilin/Progranulin Interaction as a Potential Therapy for Neurodegenerative Diseases
Ananya Mitra, PhD
05:30 PM - 06:30 PM PDT Abstract 3-004 - Integrated Alzheimer’s Disease Rating Scale (iADRS): Clinically Meaningful Change Estimates
Ellen Dennehy
05:30 PM - 06:30 PM PDT Abstract 3-005 - Design and methods of a Phase 2a study evaluating the safety, tolerability, pharmacokinetics, and CNS activity of CY6463 in participants with Alzheimer’s disease with vascular pathology
Chad E Glasser, PharmD
05:30 PM - 06:30 PM PDT Abstract 12-001 - Effect of Siponimod on Disability Progression as Measured by the Ambulation Score, a Subscore of the Neurostatus-EDSS: Post hoc Analysis of the EXPAND Trial in SPMS
Marcus D'Souza, MD
05:30 PM - 06:30 PM PDT Abstract 12-002 - Long-Term Suppression of MRI Disease Activity and Reduction of Global/Regional Volume Loss: Results from OPERA I/II and ORATORIO Open-Label Extension
Douglas L. Arnold, MD, FAAN
05:30 PM - 06:30 PM PDT Abstract 12-003 - Efficacy and safety of proposed natalizumab biosimilar PB006 versus Tysabri® in patients with relapsing remitting multiple sclerosis: Primary data from the Phase III Antelope study
Karsten Roth, MD,PhD
05:30 PM - 06:30 PM PDT Abstract 12-004 - Estimating long-term effect of siponimod on disability progression versus virtual placebo in SPMS using RPSFT model: EXPAND data up to 7 years
Bruce A. C. Cree, MD, PhD, MCR, FAAN
05:30 PM - 06:30 PM PDT Abstract 12-005 - Ublituximab Treatment Is Associated With a Significant Proportion of Patients Achieving No Evidence of Disease Activity (NEDA): Results From the Ultimate I and Ultimate II Phase 3 Studies of Ublituximab vs Teriflunomide in Relapsing Multiple Sclerosis (RMS)
Enrique Alvarez, MD, PhD
05:30 PM - 06:30 PM PDT Abstract 12-006 - Effectiveness of Natalizumab Treatment Inpatients With Early Relapsing-Remitting Multiple Sclerosis (RRMS) who were Treatment-Naive Versus Those Who Had Prior Disease-Modifying Therapy (DMT) Use
Robin L Avila, PhD
05:30 PM - 06:30 PM PDT Abstract 12-007 - Innovative Comparative Study Assessing the Effect of Siponimod on Reactive Microglia/Astrocytes in Patients With Secondary Progressive Multiple Sclerosis: Study Design
Robert Zivadinov, MD, PhD, FAAN
05:30 PM - 06:30 PM PDT Abstract 12-008 - Humoral immunological memory is retained in patients with multiple sclerosis receiving cladribine therapy
Tobias Moser
05:30 PM - 06:30 PM PDT Abstract 12-009 - Autologous HSCT Outside of Clinical Trials in Patients with Multiple Sclerosis
Jennifer Lord, MD
05:30 PM - 06:30 PM PDT Abstract 12-010 - Infusion-Related Reactions (IRRs) With Ublituximab in Patients With Relapsing Multiple Sclerosis (RMS): Post Hoc Analyses From the Phase 3 ULTIMATE I and II Studies
Edward J. Fox, MD, PhD, FAAN
05:30 PM - 06:30 PM PDT Abstract 12-011 - Guillain-Barré Syndrome After Alemtuzumab Treatment in a Patient with Multiple Sclerosis: a Case Report
Hasim Gezegen, MD
05:30 PM - 06:30 PM PDT Abstract 6-001 - Use of Lacosamide in Neonatal Seizures
Abdullah Bin Shoaib, MD
05:30 PM - 06:30 PM PDT Abstract 6-002 - Variants in PNPLA8 are Associated with Developmental Epileptic Encephalopathy and Cerebellar Atrophy.
Cheryl Fields, DO
05:30 PM - 06:30 PM PDT Abstract 6-003 - Trends in Diagnosis of Post-Stroke Depression in the U.S. (2003 – 2019)
Holly Elser, MD, PhD
05:30 PM - 06:30 PM PDT Abstract 6-004 - Sex Differences in Inpatient Outcomes following Hospitalization for Myasthenic Crisis
Maryam Jamil Syed, MBBS
05:30 PM - 06:30 PM PDT Abstract 6-005 - Neurocysticercosis in Mexico. A persistent health problem or on-track to eradication?
Roberto Rodriguez, MD
05:30 PM - 06:30 PM PDT Abstract 7-001 - Outcomes of tailored psychotherapy for dissociative seizures in a developing functional neurology service
James William Mitchell, MBChB
05:30 PM - 06:30 PM PDT Abstract 7-002 - Emotional and Behavioral Dyscontrol Is More Likely After Intracerebral Hemorrhage than Subarachnoid Hemorrhage
Daniel Talmasov, MD
05:30 PM - 06:30 PM PDT Abstract 7-004 - Wernicke-Korsakoff syndrome and catatonia: a case report
Alexandra Seide Cardoso, MD
05:30 PM - 06:30 PM PDT Abstract 7-005 - Psychogenic Non-Epileptic Seizures in the Elderly
Maheen Islam, MD
05:30 PM - 06:30 PM PDT Abstract 7-006 - Psychological Outcome after Hemorrhagic Stroke is related to Functional Status
Ariane Lewis, MD, FAAN
05:30 PM - 06:30 PM PDT Abstract 7-007 - Piperlongumine and Piperlonguminine Mitigate Rotenone Induced Neurotoxicity: Implications for a Novel Parkinson's Disease Treatment
Jessica Guo
05:30 PM - 06:30 PM PDT Abstract 7-008 - A Novel Strategy for the Reversal of Glioblastoma Tumor Cell Immortality
Samuel Wu
05:30 PM - 06:30 PM PDT Abstract 7-009 - An Integrated Genome and Phenome-Wide Association Study Approach to Understand Alzheimer’s Disease Predisposition
Archita Khaire
05:30 PM - 06:30 PM PDT Abstract 1-001 - Cerebral hypoperfusion after nimodipine administration is associated with worse functional outcomes in subarachnoid hemorrhage patients
David Bartolome
05:30 PM - 06:30 PM PDT Abstract 1-002 - Exploring the Role of Perihematomal Edema in Delirium after Intracerebral Hemorrhage
Jesse Menville
05:30 PM - 06:30 PM PDT Abstract 1-003 - National Trends In Utilization And Outcomes Of Acute Ischemic Stroke And Intracerebral Hemorrhage Patients Undergoing Gastrostomy Tube Placement
Mohammad Rauf A. Chaudhry, MD, MBBS
05:30 PM - 06:30 PM PDT Abstract 1-004 - A Quality Improvement Project to improve the Standardization of Hospital-wide Initiation of chemical VTE Prophylaxis in ICH Patients
Sang Han, MD
05:30 PM - 06:30 PM PDT Abstract 10-001 - Serotonin and Focal Epilepsy: A Therapeutic Role?
William H. Theodore, MD, FAAN
05:30 PM - 06:30 PM PDT Abstract 10-002 - Predictors of 30-day Readmission Post Index Hospitalization With Epilepsy: 5 Years National Estimate
Parisha Bhatia, MD
05:30 PM - 06:30 PM PDT Abstract 10-003 - Improved Access to Rapid Electroencephalography at a Community Hospital Reduces Inter-Hospital Transfers for Suspected Non-Convulsive Seizures
Kapil Gururangan, MD
05:30 PM - 06:30 PM PDT Abstract 10-004 - Quality of Life in Elderly Epilepsy Patients implanted with Vagus Nerve Stimulator
Ana Suller Marti, MD
05:30 PM - 06:30 PM PDT Abstract 10-005 - Insular Involvement in Cases of Epilepsy Surgery Failure
Jimmy Li, MD
05:30 PM - 06:30 PM PDT Abstract 10-006 - Suspected SCN1A gain of function mutation causing refractory neonatal seizures responsive to sodium channel blocking antiepileptics
Kelly Landry Angelle, MD
05:30 PM - 06:30 PM PDT Abstract 10-007 - The Language of Seizure Identification: A Qualitative Investigation
Ellen Snyder, MD
05:30 PM - 06:30 PM PDT Abstract 4-001 - Assessing the Impact of Adjuvant Temozolomide Duration on Survival in Patients with IDH-Mutant Low-Grade Gliomas
Isabella Densmore
05:30 PM - 06:30 PM PDT Abstract 4-002 - Sarcopenia Measured by Temporalis Muscle Thickness Independently Predicts Early Relapse and Short Survival in Primary CNS Lymphoma
Anthony Michael Menghini
05:30 PM - 06:30 PM PDT Abstract 4-003 - Single Center Experience of Dopamine Antagonist ONC-201 for Recurrent H3K27M-mutant Glioblastoma in Adults
Chukwuyem Ekhator
05:30 PM - 06:30 PM PDT Abstract 4-004 - Treatment Outcomes In Patients With H3K27 M Variant Glioma
Tejas Ranade, MD
05:30 PM - 06:30 PM PDT Abstract 4-005 - Cognitive Sequelae of Radiotherapy in Primary Brain Tumors
Sofia Ramirez Guerrero
05:30 PM - 06:30 PM PDT Abstract 4-006 - Piedmont Brain Tumor Center’s Experience with GammaTile Intracranial Brachytherapy for Malignant Intracranial Tumors
Erin M. Dunbar, MD
05:30 PM - 06:30 PM PDT Abstract 13-001 - Leukocyte Count and Neutrophil-to-Lymphocyte Ratio as Simple Hematologic Predictors of Stroke Severity and Functional Outcome in Acute Ischemic Stroke Patients
Vanessa Veronica
05:30 PM - 06:30 PM PDT Abstract 13-002 - Endoplasmic Reticulum Stress exacerbate Stroke outcome in Chronic Kidney Disease
Pallab Bhattacharya, PhD
05:30 PM - 06:30 PM PDT Abstract 13-003 - Correlation Between Plasma Glutamate Levels and Post Stroke Depression
Lea Colantonio
05:30 PM - 06:30 PM PDT Abstract 13-004 - Intracerebral Hemorrhage as a Marker for Mycotic Aneurysm in Patients with Infective Endocarditis
Thomas James Williams, MD
05:30 PM - 06:30 PM PDT Abstract 13-005 - Safety and Efficacy of Sphenopalatine Ganglion Block in Post-Stroke Headache Cohort: A Single Center Experience
Cecilia Peterson
05:30 PM - 06:30 PM PDT Abstract 13-006 - Predictors of cortical surface subarachnoid hemorrhage in reversible cerebral vasoconstriction syndrome
Oscar Emanuel Garat, MD
05:30 PM - 06:30 PM PDT Abstract 13-007 - Cannabis Use and Outcomes in Spontaneous Aneurysmal Subarachnoid Hemorrhage: A Descriptive Study
Julianne Hall, MD
05:30 PM - 06:30 PM PDT Abstract 13-008 - Characteristics of Strokes in Down Syndrome Patients, A single center decade experience
Anam Syed, DO
05:30 PM - 06:30 PM PDT Abstract 13-009 - Hypertension Associated with Functional Status Early After Hospitalization for Ischemic Stroke: a Cohort Study
Megan Elizabeth Pudlo
05:30 PM - 06:30 PM PDT Abstract 5-001 - Long-Term Efficacy and Safety of Deutetrabenazine in Patients With Tardive Dyskinesia by Concomitant Dopamine-Receptor Antagonist Use
Nayla Chaijale
05:30 PM - 06:30 PM PDT Abstract 5-002 - Genotype-specific white matter microstructural alterations in prodromal Parkinson’s disease
Amgad Droby
05:30 PM - 06:30 PM PDT Abstract 5-003 - Association between Parkinson’s disease and Acute or Subacute Subdural Hemorrhage, a Retrospective Study
Amna Imran, MD
05:30 PM - 06:30 PM PDT Abstract 5-004 - Once-Daily Valbenazine Is Effective for Tardive Dyskinesia in Elderly Patients (=65 Years)
Eric Jen
05:30 PM - 06:30 PM PDT Abstract 5-005 - Impact of Tardive Dyskinesia on Physical, Psychological, and Social Aspects of Patient Lives: A Survey of Patients and Caregivers in the United States
Rakesh Jain, Sam Leo, PharmD
05:30 PM - 06:30 PM PDT Abstract 5-006 - Using PSMD, a novel DTI measure, to assess the role of white matter disease on structural connectivity in Parkinson’s disease.
Isaac Goldszer, MD
05:30 PM - 06:30 PM PDT Abstract 5-007 - Palliative Care for Parkinson's Disease: Literature Review
Wendy Gaztanaga, MD
05:30 PM - 06:30 PM PDT Abstract 2-001 - Peripheral Neuropathy May Be the Major Cause of Imbalance in Older Patients
Akhand Pratap Singh, MBBS
05:30 PM - 06:30 PM PDT Abstract 2-002 - Isolated Hypoglossal Nerve Palsy: Two Case Reports
Robert Evan Ungerer
05:30 PM - 06:30 PM PDT Abstract 2-004 - A Rare Case of Giant Cell Arteritis Presenting With Transient Polycranial Neuropathies
Harinoor Mann, MBBS
05:30 PM - 06:30 PM PDT Abstract 2-005 - Hypokalemic periodic palsy masquerading as Guillaine Barrè syndrome
Sahil Naik, MD
05:30 PM - 06:30 PM PDT Abstract 11-001 - Efficacy of Apraclonidine in Treating Ptosis Secondary to Myasthenia Gravis
Mohamad Khodr Agha, MD
05:30 PM - 06:30 PM PDT Abstract 11-002 - Measuring Adverse Event Burden in Myasthenia Gravis: Single Center Prospective Evaluation of the Adverse Event Unit (AEU)
Michael K. Hehir, II, MD
05:30 PM - 06:30 PM PDT Abstract 11-003 - Comparison of clinical and electrophysiological characteristics in Myasthenia Gravis patients with favorable and unfavorable outcomes
Gabriel Pina Paiva, MD
05:30 PM - 06:30 PM PDT Abstract 11-004 - Myasthenic crisis patient characteristics, readmissions, treatments, and outcomes: A single center analysis
Jeffrey Mullen, MD
05:30 PM - 06:30 PM PDT Abstract 11-005 - A prospective natural history study and biorepository for patients with myasthenia gravis (EXPLORE-MG2)
Jeff Guptill, MD, FAAN
05:30 PM - 06:30 PM PDT Abstract 11-006 - Emergent Comorbid Events in First Year of Immunomodulatory Treatment in Adults With Generalized Myasthenia Gravis treated in a Neurology Clinic: A Retrospective Review
Nakul Katyal, MD
05:30 PM - 06:30 PM PDT Abstract 11-007 - Clinical and Laboratory Remission with Rituximab Treatment in anti-MuSK-positive Myasthenia Gravis Patients
Berin Inan
05:30 PM - 06:30 PM PDT Abstract 11-008 - Treatment Burden According to Patients with Generalized Myasthenia Gravis
Tuan Hoang Vu, MD
05:30 PM - 06:30 PM PDT Abstract 11-009 - A Case of Lambert Eaton Myasthenic Syndrome with Cerebellar Ataxia Complicated by Encephalopathy and Confounded by Generalized Pain
Marissa Urbano, MD
05:30 PM - 06:30 PM PDT Abstract 11-010 - Pembrolizumab Associated Myasthenia Gravis and Myocarditis Associated with Anti-striational Antibody
Swaroopa Pulivarthi, MD, MBBS
Faculty Disclosures
Priti Madhavrao Patale, Other Miss Patale has nothing to disclose.
Francesca Mazzo, PhD Dr. Mazzo has nothing to disclose.
Monika Baudler Monika Baudler has received personal compensation for serving as an employee of Roche. Monika Baudler has stock in Roche.
Michael Levy, MD, PhD, FAAN Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
Cen Zhang, MD Dr. Zhang has nothing to disclose.
Jasmine Singh, MD Dr. Singh has nothing to disclose.
Avner Thaler, MD The institution of Dr. Thaler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ABBVIE. The institution of Dr. Thaler has received research support from MJFF.
Kapil Gururangan, MD Dr. Gururangan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell Inc. Dr. Gururangan has stock in Ceribell Inc. The institution of Dr. Gururangan has received research support from NIH-NINDS. The institution of Dr. Gururangan has received research support from Leon Levy Foundation.
Debarati Ghosh Ms. Ghosh has nothing to disclose.
Daiana Micucci Daiana Dossi has nothing to disclose.
Johnny Salameh, MD, FAAN Dr. Salameh has nothing to disclose.
Karen L. Furie, MD The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. Dr. Furie has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS.
Peter Soh, MD Dr. Soh has nothing to disclose.
Ellen Dennehy Ellen Dennehy has received personal compensation for serving as an employee of Eli Lilly. Ellen Dennehy has stock in Eli Lilly.
Maryam Jamil Syed, MBBS Dr. Syed has nothing to disclose.
Tyler Kenning, MD Dr. Kenning has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stryker CMF.
Joohi Jimenez Shahed, MD Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bracket Global LLC. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpha Omega. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RegenXBio. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BlueRock Therapeutics. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PhotoPharmics. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex. The institution of Dr. Jimenez Shahed has received research support from Michael J Fox Foundation. The institution of Dr. Jimenez Shahed has received research support from Amneal. The institution of Dr. Jimenez Shahed has received research support from Annovis. The institution of Dr. Jimenez Shahed has received research support from SAGE. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Faculty with Movement Disorders Society. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Faculty with American Academy of Neurology. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Parkinson Foundation. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant on Research Grant with Florida Atlantic University. Dr. Jimenez Shahed has received personal compensation in the range of $0-$499 for serving as a Speaker with Tourette Association of America. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with NACCME.
Michael S. Weiss Michael S. Weiss has received personal compensation for serving as an employee of TG Therapeutics. Michael S. Weiss has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for TG Therapeutics. Michael S. Weiss has received stock or an ownership interest from TG Therapeutics.
Ekokobe Fonkem, DO Dr. Fonkem has received personal compensation for serving as an employee of Barrow Neurological Institute. Dr. Fonkem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Fonkem has stock in Global Cancer Technology.
Avital Yoffe Vasiliev Miss Yoffe Vasiliev has nothing to disclose.
Mudassir Farooqui, MD Dr. Farooqui has nothing to disclose.
Dana Haagen Dana Haagen has nothing to disclose.
Mariana Decheva, Other Miss Decheva has nothing to disclose.
Sharon G. Lynch, MD, FAAN The institution of Dr. Lynch has received research support from National MS society. The institution of Dr. Lynch has received research support from PCORI. The institution of Dr. Lynch has received research support from Novartis. The institution of Dr. Lynch has received research support from Roche. The institution of Dr. Lynch has received research support from Chugai. The institution of Dr. Lynch has received research support from Sanofi. The institution of Dr. Lynch has received research support from Alexion. The institution of Dr. Lynch has received research support from EMD Serono. The institution of Dr. Lynch has received research support from Celgene. The institution of Dr. Lynch has received research support from Atara. The institution of Dr. Lynch has received research support from TG Therapeutics. The institution of Dr. Lynch has received research support from Medimmune. The institution of Dr. Lynch has received research support from Anokion. The institution of Dr. Lynch has received research support from Adamas. Dr. Lynch has a non-compensated relationship as a Board Memeber of the mid-America Chapter with National MS Society that is relevant to AAN interests or activities. Dr. Lynch has a non-compensated relationship as a President of Board of Directors with Friends of MS Achievement Center that is relevant to AAN interests or activities.
Ted M. Burns, MD Dr. Burns has nothing to disclose.
Gabriel *USE ID 100767 Freitas, MD, PhD No disclosure on file
Robert A. Nicholson, PhD Dr. Nicholson has received personal compensation for serving as an employee of Eli Lilly & Company. Dr. Nicholson has stock in Eli Lilly & Company. Dr. Nicholson has received intellectual property interests from a discovery or technology relating to health care.
Ryan Tyler Lamb, MD Mr. Lamb has nothing to disclose.
Anne Tufton, MBBS Dr. Tufton has nothing to disclose.
Brian Curran Healy The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Amanda Wilhelm Amanda Wilhelm has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Jennifer A. Kim, MD Dr. Kim has nothing to disclose.
Sebastian F. Ameriso, MD Dr. Ameriso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PHRI. Dr. Ameriso has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer, Boehringer, Abbott, AstraZeneca.
Mario Emiliano Ricciardi, Sr., MD Dr. Ricciardi has nothing to disclose.
Gabriel Pina Paiva, MD Dr. Paiva has nothing to disclose.
Marissa Urbano, MD Dr. Urbano has nothing to disclose.
Michael Kurnellas Michael Kurnellas has received personal compensation for serving as an employee of Alector. Michael Kurnellas has received stock or an ownership interest from Alector. Michael Kurnellas has received intellectual property interests from a discovery or technology relating to health care.
Pamela M. Rist, PhD The institution of Dr. Rist has received research support from National Institutes of Health. The institution of Dr. Rist has received research support from Brigham and Women's Hospital.
Nicolas Rouyrre Nicolas Rouyrre has received personal compensation for serving as an employee of Novartis.
Nicholas Gross, MS Nicholas Gross, MS has nothing to disclose.
Daniel Chasman, PhD Daniel Chasman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Daniel Chasman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Daniel Chasman has received research support from Pfizer. Daniel Chasman has received intellectual property interests from a discovery or technology relating to health care.
Jason H. Margolesky, MD Dr. Margolesky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion . The institution of Dr. Margolesky has received research support from NeuroNext.
Lixin Zhang, MD, PhD Dr. Zhang has nothing to disclose.
Neel Dixit, MD Dr. Dixit has nothing to disclose.
Tanushri Bhushan, MD Dr. Bhushan has nothing to disclose.
Elizabeth McQuade, MD Dr. McQuade has nothing to disclose.
Jeff Maca, PhD Mr. Maca has nothing to disclose.
Susan Hutchinson Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alder Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Allergan Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Currax Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for electroCore. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $0-$499 for serving as a Consultant for Lundbeck Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/AbbVie. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven . Susan Hutchinson has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific . Susan Hutchinson has received publishing royalties from a publication relating to health care.
Robert Evan Ungerer Mr. Ungerer has nothing to disclose.
Alison M. Dolce, MD Dr. Dolce has nothing to disclose.
Edythe Wiggs Dr. Wiggs has nothing to disclose.
Sibyl E. Wray, MD Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb/Celgene. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche/Genentech. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/Genzyme. The institution of Dr. Wray has received research support from Biogen. The institution of Dr. Wray has received research support from Atara Biotherapeutics. The institution of Dr. Wray has received research support from Bristol Myers Squibb/Celgene. The institution of Dr. Wray has received research support from Novartis. The institution of Dr. Wray has received research support from Roche/Genentech. The institution of Dr. Wray has received research support from Sanofi/Genzyme. The institution of Dr. Wray has received research support from TG Therapeutics. The institution of Dr. Wray has received research support from EMD Serono. The institution of Dr. Wray has received research support from Pharmaceuticals Corp..
Michael L. Reed, PhD The institution of Dr. Reed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Reed has received research support from Allergan. The institution of Dr. Reed has received research support from Dr Reddy's Labs/Promius. The institution of Dr. Reed has received research support from Allay Lamp. Dr. Reed has a non-compensated relationship as a Research Analyst with National Headache Foundation that is relevant to AAN interests or activities.
Cecilia Peterson An immediate family member of Ms. Peterson has received personal compensation for serving as an employee of 100Plus.
Lily Lee, PhD Dr. Lee has nothing to disclose.
Stephen L. Hauser, MD Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to AAN interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to AAN interests or activities.
Barry M. Czeisler, MD, MS, MHPE, FAAN Dr. Czeisler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for NeuroStat Consulting LLC. Dr. Czeisler has stock in Brainspace.
Murat Kurtuncu, MD Dr. Kurtuncu has nothing to disclose.
Claudia Lopez Mrs. Lopez has nothing to disclose.
Tuan Hoang Vu, MD Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ImmunAbs. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for CSL Behring. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. Dr. Vu has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Alexion. The institution of Dr. Vu has received research support from RA Pharma/UCB. The institution of Dr. Vu has received research support from Mass Gen Hospital/Healy Platform Study. The institution of Dr. Vu has received research support from Amylyx Pharma. The institution of Dr. Vu has received research support from ARGENX. The institution of Dr. Vu has received research support from Annexon. The institution of Dr. Vu has received research support from Horizon. The institution of Dr. Vu has received research support from Woolsey Pharma. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Cartesian Therapeutics. The institution of Dr. Vu has received research support from Janssen/Momenta. The institution of Dr. Vu has received research support from Immunovant.
Reid D. Taylor, MD Dr. Taylor has nothing to disclose.
Niels Bergsland Prof. Bergsland has nothing to disclose.
Richard Jones Richard Jones has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of the American Geriatrics Society.
Douglas L. Arnold, MD, FAAN Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Celgene. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has stock in NeuroRx.
Hadas Barkay Hadas Barkay has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Noah A. Kolb, MD Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abalone Medical. Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Disarm Therapeutics. Dr. Kolb has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisana corporation. Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NINDS. Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Locks Law. Dr. Kolb has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for walk up law office . Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for ralston, pope, diehl. The institution of Dr. Kolb has received research support from National Cancer Institute.
Lori Daiello Lori Daiello has nothing to disclose.
Edward J. Fox, MD, PhD, FAAN Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Fox has received research support from Biogen. The institution of Dr. Fox has received research support from Genentech. The institution of Dr. Fox has received research support from Celgene - BMS. The institution of Dr. Fox has received research support from Chugai. The institution of Dr. Fox has received research support from Novartis. The institution of Dr. Fox has received research support from EMD-Serono. The institution of Dr. Fox has received research support from TG Therapeutics. The institution of Dr. Fox has received research support from AbbVie. The institution of Dr. Fox has received research support from Sanofi Genzyme. The institution of Dr. Fox has received research support from AbbVie.
Melissa Ann Fellman, MD Dr. Fellman has nothing to disclose.
Michelle Machie, MD Dr. Machie has nothing to disclose.
Blanca Marquez de Prado Blanca Marquez de Prado has nothing to disclose.
Jonathan C. Lau Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. The institution of Dr. Lau has received research support from NSERC.
Jacob Pellinen, MD The institution of Dr. Pellinen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life Science.
Michael K. Hehir, II, MD Dr. Hehir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Hehir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Hehir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Hehir has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Hehir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Hehir has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum- American Academy of Neurology. Dr. Hehir has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. The institution of Dr. Hehir has received research support from Myasthenia Gravis Foundation of America. The institution of Dr. Hehir has received research support from University of Vermont Medical Center.
Giovanna Manzano, MD Dr. Manzano has nothing to disclose.
Irene Dustin Irene Dustin has nothing to disclose.
Margo Sheck Breilyn, MD Dr. Breilyn has nothing to disclose.
Amelia Karen Adcock, MD The institution of an immediate family member of Dr. Adcock has received research support from NIH.
Amit Bar-Or, MD, FRCPC Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen/Actelion. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atara Biotherapeutics. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech. The institution of Dr. Bar-Or has received research support from Merck/EMD Serono.
Soudeh Ansari Soudeh Ansari has received personal compensation for serving as an employee of Novartis.
Oscar Emanuel Garat, MD Mr. Garat has nothing to disclose.
Ferdinand Schweser, PhD Dr. Schweser has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Sean Power Sean Power has received personal compensation for serving as an employee of TG Therapeutics, Inc. Sean Power has received stock or an ownership interest from TG Therapuetics, Inc..
Wendy Mack Wendy Mack has received personal compensation for serving as an employee of University of Southern California. Wendy Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Wendy Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wake Forest University. Wendy Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Virginia Commonwealth University. The institution of Wendy Mack has received research support from NIH.
Cheryl Fields, DO Dr. Fields has nothing to disclose.
Swaroopa Pulivarthi, MD, MBBS Dr. Pulivarthi has nothing to disclose.
Michael J. Schwartzman, DO Dr. Schwartzman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx .
Sofia Ramirez Guerrero Ms. Ramirez Guerrero has nothing to disclose.
Mahmoud Al Masry, MD Dr. Al Masry has nothing to disclose.
Christina Lynch Szperka, MD The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Upsher Smith. The institution of Dr. Szperka has received research support from NINDS. The institution of Dr. Szperka has received research support from PCORI. The institution of Dr. Szperka has received research support from International Headache Society.
Jessica Frey, MD The institution of Dr. Frey has received research support from Tourette Association of America.
Chad E Glasser, PharmD Mr. Glasser has received personal compensation for serving as an employee of Cyclerion Therapeutics. Inc. Mr. Glasser has stock in Cyclerion Therapeutics Inc.. Mr. Glasser has received intellectual property interests from a discovery or technology relating to health care.
Marissa Marie Castillo Ms. Castillo has nothing to disclose.
Robert J. Fox, MD, FAAN Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for INmune Bio. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lily. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Biosciences. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
Robert Paul, MD, PhD Dr. Paul has received personal compensation for serving as an employee of Alector. Dr. Paul has received stock or an ownership interest from Alector.
Jerome J. Graber, MD, MPH, FAAN Dr. Graber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Academy of Neurology. Dr. Graber has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dickie McCamey Attorneys at Law. Dr. Graber has a non-compensated relationship as a Editorial Board member with Neuro-Oncology: Practice, published by Oxford that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Editorial Board Member with Journal of Pain and Symptom Management that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Board of Directors with American Society of Neuroimaging that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Board of Directors and Certification Exam Committee Member with United Council of Neurogical Subspecialties that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Question of the Day 'app' committee and NeuroSAE and Continuum with American Academy of Neurology that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Editorial Board Member with Practical Neurology (BMC) that is relevant to AAN interests or activities.
Santiago Ortega Gutierrez, MD Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for stryker. Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic. Dr. Ortega Gutierrez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for microvention. Dr. Ortega Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Dr. Ortega Gutierrez has received research support from stryker. The institution of Dr. Ortega Gutierrez has received research support from Medtronic. The institution of Dr. Ortega Gutierrez has received research support from Methinks. The institution of Dr. Ortega Gutierrez has received research support from NIH.
María Paula Vargas-Cuellar No disclosure on file
Eva Jolanda Muenzel, MD, PhD Dr. Muenzel has received personal compensation for serving as an employee of Eli Lilly and Company.
Isidora Rose Beach Ms. Beach has received personal compensation for serving as an employee of ARIS Solutions.
Karen Stephenson Ms. Stephenson has nothing to disclose.
Akhand Pratap Singh, MBBS Dr. Singh has nothing to disclose.
Lourdes Peralta Lourdes Peralta has nothing to disclose.
Roger Chang Roger Chang has nothing to disclose.
Indirapriya Avulakunta, MD Dr. Avulakunta has nothing to disclose.
James F. Howard, Jr., MD, FAAN Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for arenx . Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron Pharmaceuticals. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ra Pharma (now UCB Biosciences). Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi US. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Academic CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PeerView CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Platform Q CME. Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Zai Laboratories. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Medscape CME. Dr. Howard has stock in General Electric dividends. Dr. Howard has stock in Johnson & Johnson dividends. Dr. Howard has stock in Pfizer dividends. An immediate family member of Dr. Howard has stock in GlaxoSmithKline dividends. An immediate family member of Dr. Howard has stock in GE Healthcare dividends. The institution of Dr. Howard has received research support from Alexion Pharmaceuticals. The institution of Dr. Howard has received research support from argenx . The institution of Dr. Howard has received research support from UCB Biosciences. The institution of Dr. Howard has received research support from NIH. The institution of Dr. Howard has received research support from Centers for Disease Control/Research Triangle Institute. The institution of Dr. Howard has received research support from Duke University (DCRI). The institution of Dr. Howard has received research support from Cartestian Therapeutics. Dr. Howard has a non-compensated relationship as a Scientific Advisiory Board member, Committee member with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Howard has a non-compensated relationship as a Committee member with American Assoc Neuromuscular and Electrodiagnostic Medicine that is relevant to AAN interests or activities.
Nichelle Raj Nichelle Raj has nothing to disclose.
Alfredo Thomson, MD Dr. Thomson has nothing to disclose.
Dawn C. Buse, PhD Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Collegium. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
Jesica Pszenyckyj jesica Pszenyckyj has nothing to disclose.
Emily Florine Emily Florine has received personal compensation for serving as an employee of Cyclerion Therapeutics. Emily Florine has received personal compensation for serving as an employee of Ironwood Pharmaceuticals. Emily Florine has received stock or an ownership interest from Cyclerion Therapeutics. Emily Florine has received stock or an ownership interest from Ironwood Pharmaceuticals.
Yingkai Li, MD, PhD Dr. Li has nothing to disclose.
Tasha Denise Frye, Other Mrs. Frye has nothing to disclose.
Josef Hoefler, PhD Dr. Hoefler has received personal compensation for serving as an employee of Staburo GmbH.
Anam Syed, DO Dr. Syed has nothing to disclose.
Tuncay Gunduz, MD Dr. Gunduz has nothing to disclose.
Nagma Dalvi, MD Dr. Dalvi has nothing to disclose.
Varsha Muddasani, MBBS Dr. Muddasani has nothing to disclose.
Amanda Wilhelm, PhD Dr. Wilhelm has received personal compensation for serving as an employee of Teva Pharmaceuticals .
Evan Madill, MD The institution of Dr. Madill has received research support from American Academy of Neurology.
Alain Bouthillier Alain Bouthillier has nothing to disclose.
Steven Galetta, MD, FAAN Dr. Galetta has nothing to disclose.
Claudia Talero-Gutierrez Dr. Talero-Gutierrez has nothing to disclose.
Jerry S. Wolinsky, MD, FAAN Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
Ariane Lewis, MD, FAAN Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seminars in Neurology. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
Jose Biller, MD, FAAN, FACP, FAHA Dr. Biller has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer. Dr. Biller has received publishing royalties from a publication relating to health care.
Jenna Bosco Jenna Bosco has received personal compensation for serving as an employee of TG Therapeutics. Jenna Bosco has received stock or an ownership interest from TG Therapeutics.
Virginia Andrea Pujol Lereis, MD Dr. Pujol Lereis has nothing to disclose.
Aparna Polavarapu Ramarao, MD Dr. Polavarapu Ramarao has nothing to disclose.
Ilayda Top Ms. Top has nothing to disclose.
James William Mitchell, MBChB Dr. Mitchell has received research support from University of Liverpool. Dr. Mitchell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant and Research Fellow with ICHOM.
Leonardo Morantes Gomez, MD Dr. Morantes Gomez has nothing to disclose.
Frederik Barkhof, MD, PhD Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Frederik Barkhof has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Combinostics. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IXICO. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI.
Nir Giladi, MD, FAAN Dr. Giladi has received personal compensation in the range of $0-$499 for serving as a Consultant for Sionara. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDerm. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharma2B. Dr. Giladi has stock in Vibrant. Dr. Giladi has stock in Lysosomal Therapeutics . The institution of Dr. Giladi has received research support from The Michael J Fox Foundation. The institution of Dr. Giladi has received research support from The National Parkinson Foundation. The institution of Dr. Giladi has received research support from The European Union . The institution of Dr. Giladi has received research support from The Israel Science Foundation. The institution of Dr. Giladi has received research support from Biogen . The institution of Dr. Giladi has received research support from Ionis. The institution of Dr. Giladi has received research support from Sieratzki Family Foundation . The institution of Dr. Giladi has received research support from The Aufzien Academic Center in Tel-Aviv University.
Pallab Bhattacharya, PhD Dr. Bhattacharya has nothing to disclose.
Joao Aris Kouyoumdjian, PhD Dr. Kouyoumdjian has nothing to disclose.
Immaculada Aban Immaculada Aban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Immaculada Aban has received research support from NIH. The institution of Immaculada Aban has received research support from Myasthenia Gravis Foundation of America (MGFA). The institution of Immaculada Aban has received research support from Ra Pharmaceutical through MGFA. The institution of Immaculada Aban has received research support from Alexion through MGFA. The institution of Immaculada Aban has received research support from ArgenX through MGFA. The institution of Immaculada Aban has received research support from Catalyst through MGFA. The institution of Immaculada Aban has received research support from Verona. Immaculada Aban has received personal compensation in the range of $0-$499 for serving as a Data Safety Monitoring Board member with NIH NIAMS. Immaculada Aban has received personal compensation in the range of $0-$499 for serving as a Grant reviewer with NIH NINDS.
Nakul Katyal, MD Dr. Katyal has nothing to disclose.
Amna Imran, MD Dr. Imran has nothing to disclose.
Nazanin Sheibani, MD Dr. Sheibani has nothing to disclose.
Avery Berit St Sauveur Ms. St Sauveur has nothing to disclose.
Deborah I. Friedman, MD, MPH, FAAN Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Friedman has received personal compensation in the range of $0-$499 for serving as a Consultant for Satsuma. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Reviews. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology . The institution of Dr. Friedman has received research support from Spinal CSF Leak Foundation. Dr. Friedman has a non-compensated relationship as a Program Co-Chair, Scottsdale Headache Symposium with American Headache Society that is relevant to AAN interests or activities. Dr. Friedman has a non-compensated relationship as a Medical Advisor with Spinal CSF Leak Foundation that is relevant to AAN interests or activities. Dr. Friedman has a non-compensated relationship as a Treasurer, Board of Directors with Southern Headache Society that is relevant to AAN interests or activities.
Anthony J Zagar Anthony J Zagar has received personal compensation for serving as an employee of Eli Lilly.
Troy Desai, MD Dr. Desai has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Desai has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Desai has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva Neurosciences.
Alexis Lea Finer Ms. Finer has nothing to disclose.
Ahya Sajawal Ali, MD Dr. Ali has nothing to disclose.
Anthony Traboulsee, MD Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Genzyme.
Stewart A. Factor, DO, FAAN Dr. Factor has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Factor has received research support from Biohaven. The institution of Dr. Factor has received research support from Voyager. The institution of Dr. Factor has received research support from Neurocrine. The institution of Dr. Factor has received research support from Supernus. The institution of Dr. Factor has received research support from Prelinia. The institution of Dr. Factor has received research support from Medtronics. The institution of Dr. Factor has received research support from Boston Scientific. The institution of Dr. Factor has received research support from Sun Pharmaceuticals Advanced Research Company. The institution of Dr. Factor has received research support from Aspen. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care.
Rakesh Jain Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie (Allergan). Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Adamas. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alfasigma. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alkermes. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axsome. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boehringer Ingleheim. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Corium. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Evidera. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Impel. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. An immediate family member of Rakesh Jain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neos Therapeutics. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine Biosciences. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Osmotica. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Otsuka. An immediate family member of Rakesh Jain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pamlab. An immediate family member of Rakesh Jain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pamlab. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sage Therapeutics. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shire. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. An immediate family member of Rakesh Jain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Transcend Therapeutics. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie (Allergan). Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alkermes. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Corium. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Indivior. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Intra-Cellular Therapies. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Ironshore. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. An immediate family member of Rakesh Jain has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merck. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neos Therapeutics. Rakesh Jain has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Otsuka. An immediate family member of Rakesh Jain has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Pamlab. An immediate family member of Rakesh Jain has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pamlab. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Pfizer. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Shire. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. An immediate family member of Rakesh Jain has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Takeda. Rakesh Jain has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Teva. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Tris Pharmaceuticals. Rakesh Jain has received research support from AbbVie (Allergan). Rakesh Jain has received research support from Lilly. Rakesh Jain has received research support from Lundbeck. Rakesh Jain has received research support from Otsuka. Rakesh Jain has received research support from Pfizer. Rakesh Jain has received research support from Shire. Rakesh Jain has received research support from Takeda.
Jesus David Charry Sanchez, MD Dr. Charry Sanchez has nothing to disclose.
Jennifer Lord, MD Dr. Lord has nothing to disclose.
Margaret Adler, MD Dr. Adler has nothing to disclose.
Anthony Michael Menghini Mr. Menghini has nothing to disclose.
Alex Hammett No disclosure on file
Nathaniel Rex Mr. Rex has received research support from NIH Heart, Lung, Blood Institute (NHLBI) .
William H. Theodore, MD, FAAN Dr. Theodore has a non-compensated relationship as a Treasurer and vice president with American Epilepsy Society that is relevant to AAN interests or activities.
Zachary Thomas Lazzari, MD Dr. Lazzari has nothing to disclose.
Isaac Goldszer, MD Dr. Goldszer has nothing to disclose.
Alexandria Soto Ms. Soto has nothing to disclose.
Orna Rosen, MD Dr. Rosen has nothing to disclose.
Jeremy Toler, MD Dr. Toler has nothing to disclose.
Bart Chwalisz, MD Dr. Chwalisz has nothing to disclose.
Lawrence Steinman, MD, FAAN Dr. Steinman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for 180 Life Sciences. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for BioAtla. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Pasithea. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atreca. Dr. Steinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Steinman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for National Academy of Sciences. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Gibson Dunn. The institution of Dr. Steinman has received research support from Roche. The institution of Dr. Steinman has received research support from Novartis. Dr. Steinman has received intellectual property interests from a discovery or technology relating to health care.
Sami El-Dalati, MD Dr. El-Dalati has nothing to disclose.
Patrick Vermersch Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Juha M. Savola, MD,PhD Dr. Savola has received personal compensation for serving as an employee of Teva Pharmaceuticals. Dr. Savola has received intellectual property interests from a discovery or technology relating to health care.
Deepaneeta Sarmah, M. Pharm. Miss Sarmah has nothing to disclose.
Jose L. Torres, MD Dr. Torres has nothing to disclose.
Nils Petersen, MD Dr. Petersen has received research support from NIH.
Michael Ward Michael Ward has received personal compensation for serving as an employee of Alector. Michael Ward has stock in Alector. Michael Ward has received intellectual property interests from a discovery or technology relating to health care. Michael Ward has a non-compensated relationship as a Reviewer with ADDF that is relevant to AAN interests or activities.
Alexandra Seide Cardoso, MD Dr. Seide Cardoso has nothing to disclose.
Andrew D. Hershey, MD, PhD, FAHS, FAAN The institution of Dr. Hershey has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher-Smith. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Hershey has received research support from Amgen. The institution of Dr. Hershey has received research support from NIH, NINDS. The institution of Dr. Hershey has received research support from Bioahaven. The institution of Dr. Hershey has received research support from Upsher-Smith. Dr. Hershey has received publishing royalties from a publication relating to health care.
Hua Long Hua Long has received personal compensation for serving as an employee of Alector. Hua Long has received stock or an ownership interest from Alector. Hua Long has received intellectual property interests from a discovery or technology relating to health care.
Jennifer Chickering, PhD Dr. Chickering has received personal compensation for serving as an employee of Cyclerion Therapeutics. Dr. Chickering has received stock or an ownership interest from Cyclerion Therapeutics. Dr. Chickering has received stock or an ownership interest from Ironwood Pharmaceuticals.
Kelly G. Knupp, MD Dr. Knupp has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for zogenix. Dr. Knupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for encoded. Dr. Knupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for stoke. The institution of Dr. Knupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW pharmaceuticals. Dr. Knupp has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Research.
Supriya Bisht, MD Dr. Bisht has nothing to disclose.
Smilu Mohanlal Marcus D'Souza has nothing to disclose.
Dina Namiranian, MD Dr. Namiranian has nothing to disclose.
Neelam Goyal, MD Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Goyal has received research support from Argenx.
Donya Eizadkhah, MD Dr. Eizadkhah has nothing to disclose.
Can Ebru Kurt, MD Can Ebru Kurt has nothing to disclose.
Kevin Pettijohn, Other Mr. Pettijohn has nothing to disclose.
Franco Emanuel Appiani, MD Dr. Appiani has nothing to disclose.
Jennifer Lauren Thomas, MD Dr. Thomas has nothing to disclose.
Hans-Peter Hartung, MD, FAAN Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Tejas Ranade, MD Dr. Ranade has nothing to disclose.
Chirag Shah Chirag Shah has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc.
Koto Ishida, MD, FAAN Dr. Ishida has received publishing royalties from a publication relating to health care.
Harinoor Mann, MBBS Dr. Mann has nothing to disclose.
Matheus Castro, MD Dr. Castro has nothing to disclose.
Amgad Droby Amgad Droby has nothing to disclose.
Robert J. Glynn No disclosure on file
Tobias Moser Mr. Moser has nothing to disclose.
Peter M. Bingham, MD No disclosure on file
John R. Sims, MD Dr. Sims has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Sims has stock in Eli Lilly and Company.
Charles Matouk Charles Matouk has nothing to disclose.
Carlos Alberto Moreno Martinez, MD Dr. Moreno Martinez has nothing to disclose.
Khody Farahmand Khody Farahmand has received personal compensation for serving as an employee of Neurocrine Biosciences . Khody Farahmand has stock in Neurocrine.
Mark Conaway Mark Conaway has nothing to disclose.
Gary Raymond Cutter, PhD Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biodelivery Sciences International, Biogen, Click Therapeutics, Genzyme, Genentech, GW Pharmaceuticals, Immunic, Klein-Buendel Incorporated, Medimmune/Viela Bio, Medday, Merck/Serono, Neurogenesis LTD, Novartis, Osmotica Pharmaceuticals, Perception Neurosciences, Recursion/Cerexis Pharmaceuticals, Regeneron, Reckover Pharmaceuticals, Roche, TG Therapeutics.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics, AI therapeutics, AMO Pharma, Astra-Zeneca, Avexis Pharmaceuticals, Biolinerx, Brainstorm Cell Therapeutics, Bristol Meyers Squibb/Celgene, CSL Behring, Galmed Pharmaceuticals, Green Valley Pharma, Horizon Pharmaceuticals, Immunic, Karuna Therapeutics, Mapi Pharmaceuticals LTD, Merck, Mitsubishi Tanabe Pharma Holdings, Opko Biologics,Prothena Biosciences, Novartis, Regeneron, Sanofi-Aventis, Reata Pharmaceuticals, NHLBI (Protocol Review Committee), University of Texas Southwestern, University of Pennsylvania, Visioneering Technologies, Inc.. Dr. Cutter has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Waqar Waheed, MD, MBBS Dr. Waheed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB.
Helen Ismail Mrs. Ismail has nothing to disclose.
Danielle Spengler Shpiner, MD An immediate family member of Dr. Shpiner has received personal compensation for serving as an employee of University of Miami.
Saqib A. Chaudhry, MD Dr. Chaudhry has nothing to disclose.
Bernd Liedert, PhD Dr. Liedert has received personal compensation for serving as an employee of Sandoz Biopharmaceuticals. Dr. Liedert has received personal compensation for serving as an employee of Boehringer Ingelheim.
Katherine Ruzhansky, MD Dr. Ruzhansky has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Ruzhansky has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Ruzhansky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Ruzhansky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Ruzhansky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Ruzhansky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Ruzhansky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT. The institution of Dr. Ruzhansky has received research support from MGFA.
Krzysztof W. Selmaj Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Bianca Weinstock-Guttman, MD Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
M. Mateo Paz Soldan, MD, PhD Dr. Paz Soldan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Paz Soldan has received research support from National Institutes of Health. The institution of Dr. Paz Soldan has received research support from National Multiple Sclerosis Society. The institution of Dr. Paz Soldan has received research support from Western Institute for Biomedical Research. The institution of Dr. Paz Soldan has received research support from Biogen. The institution of Dr. Paz Soldan has received research support from Novartis. The institution of Dr. Paz Soldan has received research support from Clene Nanomedicine.
Jessica Kobsa Ms. Kobsa has nothing to disclose.
Ka-Ho Wong The institution of Mr. Wong has received research support from The Sumaira Foundation .
Xavier Montalban, MD, PhD, FAAN The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Rola Mahmoud, MD Dr. Mahmoud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD sorono and Bristol Myers Squibb. Dr. Mahmoud has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for biogen.
Roberta Diaz Brinton, PhD Roberta Diaz Brinton, PhD has nothing to disclose.
Geoffrey A. Kerchner, MD, PhD Dr. Kerchner has received personal compensation for serving as an employee of F. Hoffmann-La Roche, Ltd.. Dr. Kerchner has stock in F. Hoffmann-La Roche, Ltd.. Dr. Kerchner has received publishing royalties from a publication relating to health care.
Cyrill Hornuss, MD,PhD Dr. Hornuss has received personal compensation for serving as an employee of Sandoz.
Hubert H. Fernandez, MD, FAAN Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Fernandez has received research support from Biogen. The institution of Dr. Fernandez has received research support from Michael J Fox Founda. The institution of Dr. Fernandez has received research support from Roche. The institution of Dr. Fernandez has received research support from Parkinson Foundation. The institution of Dr. Fernandez has received research support from UCB. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Paisith Piriyawat, MD Dr. Piriyawat has nothing to disclose.
Keith MacDougall Keith MacDougall has nothing to disclose.
Kristine Yaffe, MD Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quintiles. Dr. Yaffe has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Alector. The institution of Dr. Yaffe has received research support from NIH. The institution of Dr. Yaffe has received research support from DOD. The institution of Dr. Yaffe has received research support from Veterans Affairs.
Daniel R. Wynn, MD Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mylan. Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Wynn has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner Life. Dr. Wynn has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Biogen. The institution of Dr. Wynn has received research support from Novartis. The institution of Dr. Wynn has received research support from Sanofi. The institution of Dr. Wynn has received research support from Adamas Pharmaceutics. The institution of Dr. Wynn has received research support from EMD Serono. The institution of Dr. Wynn has received research support from Roche. Dr. Wynn has a non-compensated relationship as a Director, Consultants in Neurology Comprehensive Care Center with National MS Society that is relevant to AAN interests or activities.
Goeril Karlsson, PhD Dr. Karlsson has received personal compensation for serving as an employee of Novartis.
Apirada Thongsing, MD Dr. Thongsing has nothing to disclose.
Isabel Victoria Narvaez- Correa, MD Dr. Narvaez- Correa has nothing to disclose.
Nivedita Jha, MD, MBBS Dr. Jha has nothing to disclose.
Jeffrey Mullen, MD Dr. Mullen has nothing to disclose.
Sarah Alexandra Nitka, DO Dr. Nitka has nothing to disclose.
Leslie Lundt Leslie Lundt has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc.
Jai Perumal, MD Dr. Perumal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Perumal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for T G therapeutics. Dr. Perumal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono.
Sang Han, MD Dr. Han has nothing to disclose.
Lea Colantonio Lea Colantonio has nothing to disclose.
Leonardo F. G. Bonilha, MD, PhD Dr. Bonilha has nothing to disclose.
Seniha N. Ozudogru, MD Dr. Ozudogru has nothing to disclose.
Elissa Yozawitz, MD Dr. Yozawitz has nothing to disclose.
Olga Boukrina Olga Boukrina has received personal compensation for serving as an employee of Kessler Foundation. The institution of Olga Boukrina has received research support from NIH. The institution of Olga Boukrina has received research support from AHA. The institution of Olga Boukrina has received research support from Flory Foundation.
Emily Jean Gilmore, MD Dr. Gilmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for carpl.ai. Dr. Gilmore has received personal compensation in the range of $0-$499 for serving as a Consultant for AAN. Dr. Gilmore has received research support from NIH.
Isadora Versiani de Lemos, MD Dr. Versiani de Lemos has nothing to disclose.
Danette J. Rutledge Ms. Rutledge has received personal compensation for serving as an employee of Biogen. Ms. Rutledge has received stock or an ownership interest from Biogen.
Aaron S. Lord, MD Dr. Lord has nothing to disclose.
Robert E. Shapiro, MD, PhD, FAAN Dr. Shapiro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Shapiro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Shapiro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Shapiro has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of New England. Dr. Shapiro has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for EEOC.
Christopher Lane Christopher Lane has received personal compensation for serving as an employee of Roche Products Limited. Christopher Lane has stock in F. Hoffman-La Roche Ltd.
Pushpa Narayanaswami, MBBS, MD, FAAN Dr. Narayanaswami has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx USA. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Muscle and Nerve, Wiley. Dr. Narayanaswami has stock in Moderna. Dr. Narayanaswami has stock in Dr. Reddys laboratories. Dr. Narayanaswami has stock in Pfizer. Dr. Narayanaswami has stock in Viatris. Dr. Narayanaswami has stock in Doximity. The institution of Dr. Narayanaswami has received research support from Alexion. Dr. Narayanaswami has a non-compensated relationship as a Member, Medical and Scientific Advisory Board with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Narayanaswami has a non-compensated relationship as a Member, Board of Directors with AANEM that is relevant to AAN interests or activities.
Patricia Ehrhard, PhD Dr. Ehrhard has received personal compensation for serving as an employee of Hoffmann-La Roche.
Mohammad-Rauf *USE ID 312142 Chaudhry, MD No disclosure on file
Yonggang Shi Yonggang Shi has nothing to disclose.
Amanda C. Guidon, MD An immediate family member of Dr. Guidon has received personal compensation for serving as an employee of GE Healthcare. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Guidon has received research support from MGFA. The institution of Dr. Guidon has received research support from Project Data Sphere. The institution of Dr. Guidon has received research support from MGNet. The institution of Dr. Guidon has received research support from MGNet. Dr. Guidon has received publishing royalties from a publication relating to health care.
Mohamad Khodr Agha, MD, MBA No disclosure on file
Rachel Beekman, MD Dr. Beekman has nothing to disclose.
Alison Searle Alison Searle has received personal compensation for serving as an employee of Roche Products Ltd. Alison Searle has received stock or an ownership interest from Roche Holding AG.
Hendrik Wessels, PhD Dr. Wessels has received personal compensation for serving as an employee of Polpharma Biologics.
Mohammad Ghatali, MD Dr. Ghatali has nothing to disclose.
Adam Wayne Nowlan, MD Dr. Nowlan has received personal compensation for serving as an employee of GT Medical. Dr. Nowlan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GT Medical.
Raja Sawaya, MD Dr. Sawaya has nothing to disclose.
Lindsey Gurin, MD Dr. Gurin has received personal compensation in the range of $0-$499 for serving as a physician reviewer with Healthcare Quality Strategies, Inc. Dr. Gurin has received personal compensation in the range of $500-$4,999 for serving as a consultant with Human Services Research Institute.
Alette Wessels Dr. Wessels has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Wessels has received stock or an ownership interest from Eli Lilly and Company.
Naomi Hughes, MD Dr. Hughes has nothing to disclose.
Adnan I. Qureshi, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Rachelle *USE ID 002343 Doody Rachelle Doody has received personal compensation for serving as an employee of F. Hoffman LaRoche/Genentech. Rachelle Doody has stock in F. Hoffman LaRoche/Genentech.
Jesse Yenchih Hsu, PhD Dr. Hsu has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for National Kidney Foundation. Dr. Hsu has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Public Library of Science. Dr. Hsu has received personal compensation in the range of $100,000-$499,999 for serving as a Assistant Professor of Biostatistics with University of Pennsylvania.
Nadine Anne Tatton, PhD Dr. Tatton has received personal compensation for serving as an employee of Alector, Inc. Dr. Tatton has received stock or an ownership interest from Alector.
Sarah Ecker, RN Ms. Ecker has nothing to disclose.
Irena Dujmovic Basuroski, MD, PhD The institution of Dr. Dujmovic Basuroski has received research support from Alexion Pharmaceuticals, Inc. The institution of Dr. Dujmovic Basuroski has received research support from Biogen MA Inc. The institution of Dr. Dujmovic Basuroski has received research support from EMD Serono Research and Development Institute, Inc . The institution of Dr. Dujmovic Basuroski has received research support from Celgene Corporation/Bristol-Myers Squibb. The institution of Dr. Dujmovic Basuroski has received research support from The Bodford Family Transverse Myelitis Center Fund.
Ali A. Habib, MD Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Immune Sciences. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH/NINDS. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunis Biomedical. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman-La Roche. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Habib has received research support from Alexion. The institution of Dr. Habib has received research support from VielaBio. The institution of Dr. Habib has received research support from Immunovant. The institution of Dr. Habib has received research support from UCB. The institution of Dr. Habib has received research support from argenx. The institution of Dr. Habib has received research support from CabalettaBio. The institution of Dr. Habib has received research support from Genentech. The institution of Dr. Habib has received research support from Regeneron.
David Jason McCracken, MD Dr. McCracken has received personal compensation for serving as an employee of GT Medical. Dr. McCracken has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GT Medical. Dr. McCracken has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GT Medical.
Kimberly O'Neill, MD Dr. O'Neill has nothing to disclose.
Julie Gallois, MD Dr. Gallois has nothing to disclose.
Jocelyn Kalkbrenner, NP Mrs. Kalkbrenner has nothing to disclose.
Guido David Vazquez, II, PhD Dr. Vazquez has nothing to disclose.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has stock in Biohaven. Dr. Lipton has stock in Manistee. Dr. Lipton has stock in Axon. Dr. Lipton has stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Georg Pilz Georg Pilz has nothing to disclose.
Denahin Hinnoutondji Toffa, MD, PhD, CSCN Denahin Hinnoutondji Toffa has nothing to disclose.
Jennifer A. Frontera, MD Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FirstKindMedical. Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Physician Education Resource. The institution of Dr. Frontera has received research support from NIH. The institution of Dr. Frontera has received research support from Alexion. Dr. Frontera has received publishing royalties from a publication relating to health care.
Priya Jagtap No disclosure on file
Mikaela Springsteen The institution of Ms. Springsteen has received research support from The Commonwealth Fund.
Coleman Cabe, Other Mr. Cabe has nothing to disclose.
Carla Florencia Bolano Diaz, MD Dr. Bolano Diaz has nothing to disclose.
Christine Emma Burness, MD,MB,ChB,MR,CP Dr. Burness has nothing to disclose.
Ahmed Osameh Alwahaidy Mr. Alwahaidy has nothing to disclose.
Dang Khoa Nguyen, MD,PhD The institution of Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Paladin Labs. The institution of Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai.
Caitlin Radnis, MD Dr. Radnis has nothing to disclose.
Vanessa Veronica Ms. Veronica has nothing to disclose.
Ellen Snyder, MD Dr. Snyder has nothing to disclose.
Muthu Kuzhali Ganapathy, MBBS Dr. Ganapathy has nothing to disclose.
Daniel Talmasov, MD Dr. Talmasov has nothing to disclose.
Darko Ernesto Quispe Orozco, MD Dr. Quispe Orozco has nothing to disclose.
Rizaldy Taslim Pinzon, MD,PhD Dr. Pinzon has nothing to disclose.
Wei Wei Wei Wei has received personal compensation for serving as an employee of Hoffmann -La Roche. Wei Wei has received stock or an ownership interest from Hoffmann-La Roche.
Huiam Mubarak, MD Dr. Mubarak has nothing to disclose.
Jeff Guptill, MD, FAAN Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has stock in argenx.
Erin M. Dunbar, MD Dr. Dunbar has nothing to disclose.
Gerson David Hernandez Rivera, MD, MPH Dr. Hernandez Rivera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuTherapeutics. The institution of Dr. Hernandez Rivera has received research support from National Institute on Aging. The institution of Dr. Hernandez Rivera has received research support from National Institute on Aging.
Antra Chaudhary, M.S. (Pharm.) Ms. CHAUDHARY has nothing to disclose.
Varun Singh No disclosure on file
Paulo Pacheco Fontoura, MD, PhD, FAAN Dr. Fontoura has received personal compensation for serving as an employee of F. Hoffmann La Roche. Dr. Fontoura has stock in Roche Pharmaceuticals.
Jared Scott Hollinger, MD Dr. Hollinger has nothing to disclose.
Ralf Gold, MD Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Francois Dubeau, MD Dr. Dubeau has nothing to disclose.
Brendan Lee McNeish, MD Dr. McNeish has received research support from NIH.
Phebe Wilson No disclosure on file
Michael Joel Schneck, MD, FAAN An immediate family member of Dr. Schneck has received personal compensation for serving as an employee of Cellcarta. Dr. Schneck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for HLT Medical. Dr. Schneck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miscellaneous legal firms. Dr. Schneck has stock in Baxter Labs. The institution of Dr. Schneck has received research support from NIH.
Kathryn Cote, MPH Ms. Cote has nothing to disclose.
Scott Collins Scott Collins has nothing to disclose.
Vi Tran, MD Dr. Tran has nothing to disclose.
Gustavo J. Rodriguez, MD Dr. Rodriguez has nothing to disclose.
David Bartolome Mr. Bartolome has nothing to disclose.
Neena Viswanathan, MD Dr. Viswanathan has nothing to disclose.
Meng Law No disclosure on file
Anjali Asthana Anjali Asthana has received personal compensation for serving as an employee of Rush University Medical Center.
Isabella Densmore Ms. Densmore has nothing to disclose.
Dorene M. Rentz, PsyD Dr. Rentz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Digital Cognition Technologies. Dr. Rentz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurotrack.
Christine Cooper, MD Dr. Cooper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acorda. Dr. Cooper has received research support from NIH. Dr. Cooper has received research support from Ralph H Johnson VA Medical Center.
Robert Zivadinov, MD, PhD, FAAN The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Filterlex. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for 3D Communications. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Live. The institution of Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Dileep R. Yavagal, MD, FAAN Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vascular Dynamics. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. The institution of Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus/Johnson & Johnson. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Poseydon. Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Athersys. Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gravity Medical Technology. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Poseydon. Dr. Yavagal has stock in Poseydon. Dr. Yavagal has stock in Galaxy Therapeutics. Dr. Yavagal has stock in Stentrode. Dr. Yavagal has stock in Gravity Medical. Dr. Yavagal has stock in Gravity Medical Technology. Dr. Yavagal has stock in Athersys. Dr. Yavagal has stock in Rapid Medical . Dr. Yavagal has received intellectual property interests from a discovery or technology relating to health care. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Expert with Royal Carribean Cruise Line. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Consultant with Carnival Cruise Line.
Ersin Tan, MD Dr. Tan has nothing to disclose.
Derrick Robertson, MD Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Greenwich Biosciences. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mallinckrodt. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PRIME CME. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McVeigh. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Mccumber. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Goodis. The institution of Dr. Robertson has received research support from Biogen. The institution of Dr. Robertson has received research support from EMD Serono. The institution of Dr. Robertson has received research support from Jansenn. The institution of Dr. Robertson has received research support from Genentech. The institution of Dr. Robertson has received research support from Patient-Centered Outcomes Research Institute. The institution of Dr. Robertson has received research support from Novartis. The institution of Dr. Robertson has received research support from Sanofi Genzyme. The institution of Dr. Robertson has received research support from TG Therapeutics. The institution of Dr. Robertson has received research support from Prime. The institution of Dr. Robertson has received research support from Greenwich Biosciences. The institution of Dr. Robertson has received research support from Atara Biotherapeutics. The institution of Dr. Robertson has received research support from CorEvitas. The institution of Dr. Robertson has received research support from Anokion. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Consortium of Multiple Sclerosis Centers. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Multiple Sclerosis Association of America.
Deren Huang, MD Dr. Huang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Huang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech.
Prashanth Krishnamohan, MD Dr. Krishnamohan has nothing to disclose.
Elizabeth Chen No disclosure on file
Emma Jost-Price, Other Ms. Jost-Price has received personal compensation for serving as an employee of Rhythm Pharmaceuticals.
Solomon L. Moshe, MD, FAAN Dr. Moshe has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Moshe has received publishing royalties from a publication relating to health care. Dr. Moshe has received personal compensation in the range of $500-$4,999 for serving as a Reviewer of study sections with NINDS.
Henry J. Kaminski, MD, FAAN The institution of Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Kaminski has stock in ARC Biotechnology. The institution of Dr. Kaminski has received research support from National Institutes of Health. Dr. Kaminski has received publishing royalties from a publication relating to health care.
John W. Rose, MD, FAAN The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Gerardo *use 387725 Velasquez Gerardo Velasquez has nothing to disclose.
Sandeep Singh, MD Dr. Singh has nothing to disclose.
Kahtan Fadah, DO Dr. Fadah has nothing to disclose.
Viviane Tavares Carvalho, MD Dr. Carvalho has nothing to disclose.
Sami Kaldawi, DO Dr. Kaldawi has nothing to disclose.
Peiqing Qian, MD Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS.
Harald Kropshofer Harald Kropshofer has nothing to disclose.
Shamik Bhattacharyya, MD, FAAN Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Merck. The institution of Dr. Bhattacharyya has received research support from Alexion Pharmaceuticals. The institution of Dr. Bhattacharyya has received research support from National Institute of Health. The institution of Dr. Bhattacharyya has received research support from UCB. The institution of Dr. Bhattacharyya has received research support from Genentech. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care.
Danielle Kei Pua, MD Ms. Pua has nothing to disclose.
Heinz Wiendl, MD, FAAN Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NexGen. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Worldwide Clinical Trials. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gossamer Bio. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Toleranzia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Kayla Navarro Miss Navarro has nothing to disclose.
Cheryl Barner Ms. Barner has nothing to disclose.
Anantha Ramana Vellipuram, MD Dr. Vellipuram has nothing to disclose.
Courtney Pollard III No disclosure on file
Gavin Giovannoni, MD Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Japanese Tobacco. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aurinia Pharmaceuticals. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Oxford Health Policy Forum. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Peervoice. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Bristows .
Rachel Munik Madhur, MD No disclosure on file
Holly Elser, MD, PhD Dr. Elser has nothing to disclose.
Laura Gaetano Laura Gaetano has received personal compensation for serving as an employee of Roche. Laura Gaetano has received stock or an ownership interest from Roche.
Marcia Cristina Antu Ribas Marcia Cristina Antu Ribas has nothing to disclose.
Maryam Matloub, MD Dr. Matloub has nothing to disclose.
Mohammad Ali Shahab, MD, MBBS Dr. Shahab has nothing to disclose.
Sahil Naik, MD Dr. Naik has nothing to disclose.
Roberto Rodriguez, MD Dr. Rodriguez has nothing to disclose.
Zach Porterfield, MD,PhD Dr. Porterfield has nothing to disclose.
Yelyzaveta Begunova Miss Begunova has nothing to disclose.
Carlos Santiago Claverie, MD No disclosure on file
Alipi Bonm Dr. Bonm has nothing to disclose.
Karen E. Anderson Ms. Anderson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for teva. Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. The institution of Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for novartis. The institution of Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Biogen. Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Ms. Anderson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for neurocrine. Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medscape. Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for atheneum. Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GLG. Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving as a scientific advisor with CHDI.
Rajeev Ayyagari, PhD Rajeev Ayyagari, PhD has received personal compensation for serving as an employee of Analysis Group, Inc. .
Michael G. Dwyer, III, MD, PhD Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
Kelly Landry Angelle, MD Dr. Angelle has nothing to disclose.
Gauri Garg Ms. Garg has nothing to disclose.
Asad Rehman, DO Dr. Rehman has nothing to disclose.
Yasir Al-Khalili, MD, FAAN Dr. Al-Khalili has nothing to disclose.
Pria Anand, MD Dr. Anand has nothing to disclose.
Abdullah Bin Shoaib, MD Dr. Shoaib has nothing to disclose.
Antonio Moya, MD Dr. Moya has nothing to disclose.
Flora Chang Ms. Chang has nothing to disclose.
William A. Kilgo, MD Dr. Kilgo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Kilgo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Kilgo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Kilgo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Koby Mok, PhD Dr. Mok has received personal compensation for serving as an employee of TG Therapeutics. Dr. Mok has received stock or an ownership interest from TG Therapeutics.
Suraj Muley, MD, FAAN Dr. Muley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Muley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Muley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Muley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Muley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Muley has received publishing royalties from a publication relating to health care.
Bruce A. C. Cree, MD, PhD, MCR, FAAN The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avotres. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. Dr. Cree has received publishing royalties from a publication relating to health care.
Xiaoyang Li, MD Dr. Li has nothing to disclose.
Christopher Wright Christopher Wright has received personal compensation for serving as an employee of Cyclerion. Christopher Wright has received personal compensation for serving as an employee of AavantiBio. Christopher Wright has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cyclerion. Christopher Wright has received stock or an ownership interest from Cyclerion. Christopher Wright has received stock or an ownership interest from AavantiBio. The institution of Christopher Wright has received research support from Alzheimer's Association.
Berin Inan Berin Inan has nothing to disclose.
Ludwig Kappos, MD, FAAN The institution of Dr. Kappos has received research support from Bayer. The institution of Dr. Kappos has received research support from Biogen. The institution of Dr. Kappos has received research support from Genentech. The institution of Dr. Kappos has received research support from Genzyme. The institution of Dr. Kappos has received research support from Janssen. The institution of Dr. Kappos has received research support from Merck Serono. The institution of Dr. Kappos has received research support from Minoryx. The institution of Dr. Kappos has received research support from Novartis. The institution of Dr. Kappos has received research support from Roche. The institution of Dr. Kappos has received research support from Sanofi. The institution of Dr. Kappos has received research support from Santhera. The institution of Dr. Kappos has received research support from Swiss MS Society, Swiss National Research Foundation, European Union, Roche Research Foundation, Innosuisse. The institution of Dr. Kappos has received research support from Shionogi. The institution of Dr. Kappos has received research support from Japan Tobacco. The institution of Dr. Kappos has received research support from Auriga Vision AG. The institution of Dr. Kappos has received research support from EMD Serono. The institution of Dr. Kappos has received research support from Glaxo Smith Kline. The institution of Dr. Kappos has received research support from Wellmera AG. The institution of Dr. Kappos has received research support from Eli Lilly (Suisse) SA. The institution of Dr. Kappos has received research support from Bristol Myers Squibb. The institution of Dr. Kappos has received research support from Celltrion Inc. Dr. Kappos has received intellectual property interests from a discovery or technology relating to health care.
Sevim *Use 395876 Ozdamar Sevim Ozdamar has nothing to disclose.
Agnès Fleury, MD Dr. Fleury has nothing to disclose.
Michael A. Rogawski, MD, PhD Dr. Rogawski has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Xenon Pharmaceuticals.
Betty C. Soliven, MD Dr. Soliven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS Pharmacy. The institution of Dr. Soliven has received research support from NIH. The institution of Dr. Soliven has received research support from NIH. The institution of Dr. Soliven has received research support from Alexion. The institution of Dr. Soliven has received research support from Roche/Genentech.
Danielle Joy Kellier The institution of Ms. Kellier has received research support from National Institute of Neurological Disorders and Stroke.
Cynthia M. Stonnington, MD Dr. Stonnington has nothing to disclose.
Carolina Cuello-Oderiz, MD Dr. Cuello-Oderiz has nothing to disclose.
Adam De Havenon, MD, FAAN Dr. De Havenon has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has stock in Certus. Dr. De Havenon has stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Saif Ullah, MD Dr. Ullah has nothing to disclose.
Megan Elizabeth Pudlo Ms. Pudlo has nothing to disclose.
Lon Schneider, MD Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immue. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biovie. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Athira. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpha-cognition. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Corium. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortexyme. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurim Ltd. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. The institution of Dr. Schneider has received research support from NIH. The institution of Dr. Schneider has received research support from Eli Lilly. The institution of Dr. Schneider has received research support from Biogen. The institution of Dr. Schneider has received research support from Biohaven.
Sait Ashina, MD Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Ashina has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Neuropharma. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer.
Robert A. Hauser, MD, MBA, FAAN Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Global Kinetics Consulting (GKC). Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin Pharmaceuticals. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroDerm. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion Neurostim LLC. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion Pharmaceuticals. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tolmar Inc.. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus Pharma. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inhibikase. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pharma 2 B. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivifi Biotech. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ovid Therapeutics. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AgeX Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avanex. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MDCE Suzhou. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedRhythms. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PDNeurotechnology. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Regenxbio. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Tremor Research Support Group. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tris Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda Therapeutics. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Ameal . Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sunovion. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Cerevel. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Inhibikase. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has stock in Inhibikase. Dr. Hauser has stock in Axial Therapeutics. Dr. Hauser has stock in Enterin. Dr. Hauser has stock in Revance Therapeutics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Artizan Biosciences. The institution of Dr. Hauser has received research support from Parkinsons & Movement Disorder Alliance. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Aeon Biopharma. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Bukwang Pharmaceutical Co., Ltd.. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Cynapsus Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Impax Labratories. The institution of Dr. Hauser has received research support from Integrative Research Labratories Sweden. The institution of Dr. Hauser has received research support from Lundbeck, Inc.. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuraly Inc.. The institution of Dr. Hauser has received research support from Neurocrine Biosciences. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Pharma Two B Ltd.. The institution of Dr. Hauser has received research support from Revance Therapeutics. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Sanofi Pharmaceuticals. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from SunPharma. The institution of Dr. Hauser has received research support from UCB BioPharma. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Ananya Mitra, PhD Dr. Mitra has received personal compensation for serving as an employee of Alector Biotechnology. Dr. Mitra has stock in Alector Biotechnology. Dr. Mitra has received intellectual property interests from a discovery or technology relating to health care.
Faheem Gulamabbas Sheriff, MD Dr. Sheriff has nothing to disclose.
Daniela Piani Meier Daniela Piani Meier has received personal compensation for serving as an employee of Novartis Pharma AG.
John T. Farrar, MD Dr. Farrar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharma. Dr. Farrar has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for PharamcoEpidemiology and Drug Safety. The institution of Dr. Farrar has received research support from Food and Drug Administration . The institution of Dr. Farrar has received research support from NIH .
Georgia Grace Keller Edwards Ms. Edwards has received personal compensation for serving as an employee of Analysis Group.
Richard J. Nowak, MD Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bio. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cour Pharma. The institution of Dr. Nowak has received research support from Ra Pharma. The institution of Dr. Nowak has received research support from Alexion . The institution of Dr. Nowak has received research support from Momenta . The institution of Dr. Nowak has received research support from Immunovant . Dr. Nowak has received research support from argenx. Dr. Nowak has received research support from Viela Bio . Dr. Nowak has a non-compensated relationship as a Member of the Board of Directors with Myasthenia Gravis Foundation of America (MGFA) that is relevant to AAN interests or activities.
Dawn Matthews Dawn Matthews has received personal compensation for serving as an employee of ADM Diagnostics, Inc. Dawn Matthews has received stock or an ownership interest from ADM Diagnostics Inc. The institution of Dawn Matthews has received research support from National Institutes of Health.
Dejan Jakimovski, MD, PhD Dr. Jakimovski has nothing to disclose.
Anat Mirelman Anat Mirelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie . Anat Mirelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. The institution of Anat Mirelman has received research support from Department of Defense. The institution of Anat Mirelman has received research support from MJFF. The institution of Anat Mirelman has received research support from JPND. The institution of Anat Mirelman has received research support from EU-Horizon 2020.
Chukwuyem Ekhator Mr. Ekhator has nothing to disclose.
Ulrike Bonati Ulrike Bonati has received personal compensation for serving as an employee of Hoffman-La Roche. An immediate family member of Ulrike Bonati has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for InnoHeart. The institution of an immediate family member of Ulrike Bonati has received research support from Astra Zeneca . The institution of an immediate family member of Ulrike Bonati has received research support from Bayer. The institution of an immediate family member of Ulrike Bonati has received research support from Stiftung zur Förderung der gastroenterologischen und allgemeinen klinischen Forschung sowie der medizinischen Bildauswertung. The institution of an immediate family member of Ulrike Bonati has received research support from Swiss Heart Foundation. The institution of an immediate family member of Ulrike Bonati has received research support from Swiss National Science Foundation.
Grace Marie Nicole Biso, MD Dr. Biso has nothing to disclose.
Julie E. Buring Julie E. Buring has nothing to disclose.
Shanti S. Thirumalai, MD Dr. Thirumalai has nothing to disclose.
Wendy Gaztanaga, MD Miss Gaztanaga has nothing to disclose.
Martha Sajatovic, 5110 Martha Sajatovic, 5110 has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alkermes, Otsuka, Janssen, Myriad, Health Analytics, Frontline Medical Communications. The institution of Martha Sajatovic, 5110 has received research support from Nuromate, Otsuka, Alkermes, International Society for Bipolar Disorders (ISBD), National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Patient-Centered Outcomes Research Institute (PCORI). Martha Sajatovic, 5110 has received publishing royalties from a publication relating to health care.
Mark Forrest Gordon, MD, FAAN Dr. Gordon has received personal compensation for serving as an employee of Teva. Dr. Gordon has stock in Teva.
Jesse Menville Ms. Menville has nothing to disclose.
Taylor Meece, Other Ms. Meece has nothing to disclose.
Ayush Prasad Mr. Prasad has nothing to disclose.
Santiago O'Neill No disclosure on file
Vivek Barun, DM Dr. Varun has nothing to disclose.
Kara R. Melmed, MD Dr. Melmed has nothing to disclose.
Maheen Islam, MD Dr. Islam has nothing to disclose.
Alfred Balasa, MD Dr. Balasa has nothing to disclose.
Tobias Kurth, MD, ScD Dr. Kurth has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TotalEnergies. Dr. Kurth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly & Company. Dr. Kurth has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ. Dr. Kurth has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers. The institution of Dr. Kurth has received research support from German Joint Committee. The institution of Dr. Kurth has received research support from Ministry of Health.
Bailey Munro Sheldon, PhD Dr. Munro Sheldon has nothing to disclose.
Jayne Martlew, Other Dr. Martlew has nothing to disclose.
Avneet Hans, MD Ms. Hans has nothing to disclose.
Eric M. Pearlman, MD Dr. Pearlman has received personal compensation for serving as an employee of Eli Lilly and Co. Dr. Pearlman has received stock or an ownership interest from Eli Lilly and Co.
Caroline Bittar Braune, MD Dr. Braune has nothing to disclose.
Rachel Evans, MD No disclosure on file
Aishika Datta Aishika Datta has nothing to disclose.
Rebecca L. Sugg, MD, FAAN Dr. Sugg has nothing to disclose.
Kevin N. Sheth, MD, FAAN Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Karsten Roth, MD,PhD Dr. Roth has received personal compensation for serving as an employee of Polpharma Biologics.
Naureen Narula Ms. Narula has nothing to disclose.
Sam Leo, PharmD Dr. Leo has received personal compensation for serving as an employee of Teva Pharmaceutical Industries.
Ralph H. B. Benedict, PhD Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Benedict has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Benedict has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Brystal Mier Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Benedict has received research support from Genzyme. The institution of Dr. Benedict has received research support from Biogen. The institution of Dr. Benedict has received research support from Bristol Myer Squib. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Ivan Da Silva, MD Dr. Da Silva has nothing to disclose.
Michael G. Case, MS Mr. Case has received personal compensation for serving as an employee of Eli Lilly and Company. Mr. Case has received stock or an ownership interest from Eli Lilly and Company.
Andrea L.C. Schneider, MD, PhD Dr. Schneider has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN - Neurology.
Mefkure Eraksoy, MD Dr. Eraksoy has nothing to disclose.
Leslie D. Delfiner, MD Dr. Delfiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Delfiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Gene Therapies. Dr. Delfiner has received personal compensation in the range of $500-$4,999 for serving as a MDA Engage Event Chair and speaker with Muscular Dystrophy Association.
Danish Kherani, MD Dr. Kherani has nothing to disclose.
Roumen D. Balabanov, MD Dr. Balabanov has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Balabanov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Balabanov has received research support from NextCure. The institution of Dr. Balabanov has received research support from Biogen. The institution of Dr. Balabanov has received research support from NINDS.
Ozgu Kizek, MD Dr. Kizek has nothing to disclose.
Laura J. Balcer, MD, MSCE, FAAN An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia. Dr. Balcer has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for North American Neuro-Ophthalmology Society.
Angeliki Thanasopoulou Angeliki Thanasopoulou has received personal compensation for serving as an employee of Roche.
Iftekhar Ahmed, MD, PC, FAAN Dr. Ahmed has nothing to disclose.
Michelle Rae Caunca, MD, PhD Ms. Caunca has nothing to disclose.
Steven L. Kugler, MD Dr. Kugler has nothing to disclose.
Julianne Hall, MD Dr. Hall has nothing to disclose.
Guang Tu Guang Tu has received personal compensation for serving as an employee of Alector. Guang Tu has received stock or an ownership interest from Alector.
Warda Faridi, MD Dr. Faridi has nothing to disclose.
Ramin Rak, MD Dr. Rak has nothing to disclose.
Jai Grewal, MD The institution of Dr. Grewal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivacitas Oncology. The institution of Dr. Grewal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZeneca. The institution of Dr. Grewal has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BRANY IRB. Dr. Grewal has received stock or an ownership interest from Genomet, Inc. The institution of Dr. Grewal has received research support from Oncoceutics Pharmaceuticals.
Thomas James Williams, MD Dr. Williams has nothing to disclose.
Peter Wipfler Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Nicole Lucie Tweedy, DO Dr. Tweedy has nothing to disclose.
David Rehkopf David Rehkopf has nothing to disclose.
Donald B. Sanders, MD, FAAN Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant Health Services. Dr. Sanders has received personal compensation in the range of $0-$499 for serving as a Consultant for Cabaletta BIO. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kashiv Biosciences. Dr. Sanders has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta Pharmaceuticals. Dr. Sanders has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen RnD. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-aventis. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VielaBio. Dr. Sanders has received publishing royalties from a publication relating to health care.
Nicholas Koenig Mr. Koenig has nothing to disclose.
Jordan Lee Preston, MD Dr. Preston has nothing to disclose.
Stella McCaughey, PhD Dr. McCaughey has received personal compensation for serving as an employee of Alector, Inc. Dr. McCaughey has received stock or an ownership interest from Alector, Inc.
Sonia Pawluczyk, MD Dr. Pawluczyk has nothing to disclose.
Robin L Avila, PhD Mrs. Avila has received personal compensation for serving as an employee of Biogen. Mrs. Avila has stock in Biogen.
Ana Suller Marti, MD Dr. Suller Marti has nothing to disclose.
Lester Y. Leung, MD Dr. Leung has received research support from NIH.
Karishma Anjuli Popli, MD, MBE Dr. Popli has nothing to disclose.
Tresa McGranahan, MD Dr. McGranahan has nothing to disclose.
Sarah King No disclosure on file
Jimmy Li, MD Dr. Li has received research support from Fonds de recherche du Québec - Santé. Dr. Li has received research support from Brain Canada.
Leslie Marinelli, Other Mrs. Marinelli has nothing to disclose.
Anlys Olivera, MD, PhD Dr. Olivera has nothing to disclose.
Paul Delmar Paul Delmar has received personal compensation for serving as an employee of F.Hoffmann -La Roche AG.
Jennifer L. Cox, PhD Dr. Cox has nothing to disclose.
Moran Artzi No disclosure on file
Christopher Winrow Christopher Winrow has received personal compensation for serving as an employee of Cyclerion Therapeutics. Christopher Winrow has received personal compensation for serving as an employee of Ironwood Pharmaceuticals. Christopher Winrow has received stock or an ownership interest from Cyclerion Therapeutics. Christopher Winrow has received stock or an ownership interest from Ironwood Pharmaceuticals.
Jorge G. Burneo, MD, MSPH, FAAN Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier, Clinical Neurology and Neurosurgery Journal. Dr. Burneo has received research support from The Jack Cowin Endowed Chair in Epilepsy Research. Dr. Burneo has received publishing royalties from a publication relating to health care.
Enrique Alvarez, MD, PhD Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Motric Bio.
Raghav Govindarajan, MD, FAAN Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Cynthia Zevallos Cynthia Zevallos has nothing to disclose.
Alberto Maud, MD Dr. Maud has nothing to disclose.
Sandra Reiter-Campeau, MD Dr. Reiter-Campeau has nothing to disclose.
Bernhard Hemmer, MD No disclosure on file
Parisha Bhatia, MD Dr. Bhatia has nothing to disclose.
Rebecca F. Gottesman, MD Dr. Gottesman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Gottesman has received research support from NIH.
Katie Robb, Other Miss Robb has nothing to disclose.
Denis Tan Kerim Balaban, MD The institution of Dr. Balaban has received research support from Biogen.
Baljinder Singh No disclosure on file
Hasim *Use 360420 Gezegen, MD Dr. Gezegen has nothing to disclose.
Mohammad Rauf A. Chaudhry, MD, MBBS Dr. Chaudhry has nothing to disclose.
Ayaz M. Khawaja, MD Dr. Khawaja has nothing to disclose.
Ismael Calandri, MD Dr. Calandri has nothing to disclose.
Julieta Rosales Ms. Rosales has nothing to disclose.
Daniel Esteban Mafla Delgado, Sr., MD Dr. Mafla Delgado has nothing to disclose.
Jessica Guo No disclosure on file
Samuel Wu Samuel Wu has nothing to disclose.
Archita Khaire Archita Khaire has nothing to disclose.
Murali Krishna Gurram, MD Dr. Gurram has nothing to disclose.
Mohamad Khodr Agha, MD Dr. Khodr Agha has nothing to disclose.
Zain Ashary, MD Dr. Ashary has nothing to disclose.
Tejinder Singh, MD Dr. Singh has nothing to disclose.
Erik Roberson, MD, PhD Dr. Roberson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. The institution of Dr. Roberson has received research support from NIH. The institution of Dr. Roberson has received research support from Alzheimer's Drug Discovery Foundation. The institution of Dr. Roberson has received research support from Bluefield Project. Dr. Roberson has received intellectual property interests from a discovery or technology relating to health care. Dr. Roberson has received publishing royalties from a publication relating to health care.
Andrew Arrant, PhD Dr. Arrant has received research support from NIA. Dr. Arrant has received research support from The Association for Frontotemporal Degeneration.
Amanda Thuringer, DO No disclosure on file
Nayla Chaijale Nayla Chaijale has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Eric Jen Eric Jen has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc.
Hasim Gezegen, MD Mr. Gezegen has nothing to disclose.
Marcus D'Souza, MD Dr. D'Souza has nothing to disclose.